Radiant Pharma
13 August, 2025

A Day of Insightful Dialogue and Collaborative Spirit | Novartis Bangladesh Limited Townhall 2025

Share

On July 21st, 2025, Novartis Bangladesh Limited (NBL) hosted its annual townhall at the Radisson Hotel, Dhaka – an inspiring gathering of Novartis management associates and invited colleagues from Radiant Pharmaceuticals Limited.

The event was graced by the presence of Mr. Md. Nasser Shahrear Zahedee, Chairman of Radiant Pharmaceuticals Limited, and Mr. Musawath Shams Zahedee, Managing Director of Novartis Bangladesh Limited. Their leadership and vision set a compelling tone for the day.

From impactful keynote addresses to strategic presentations and a lively open forum, the event offered a meaningful platform for reflection, alignment, and future-focused dialogue. The collaboration between Novartis and Radiant continues to drive innovation and excellence in the pharmaceutical landscape of Bangladesh.

Grateful to all who contributed to the success of this townhall. Looking forward to the continued synergy and shared growth ahead.

Share
Radiant Pharma
Table of Contents

On July 21st, 2025, Novartis Bangladesh Limited (NBL) hosted its annual townhall at the Radisson Hotel, Dhaka – an inspiring gathering of Novartis management associates and invited colleagues from Radiant Pharmaceuticals Limited.

The event was graced by the presence of Mr. Md. Nasser Shahrear Zahedee, Chairman of Radiant Pharmaceuticals Limited, and Mr. Musawath Shams Zahedee, Managing Director of Novartis Bangladesh Limited. Their leadership and vision set a compelling tone for the day.

From impactful keynote addresses to strategic presentations and a lively open forum, the event offered a meaningful platform for reflection, alignment, and future-focused dialogue. The collaboration between Novartis and Radiant continues to drive innovation and excellence in the pharmaceutical landscape of Bangladesh.

Grateful to all who contributed to the success of this townhall. Looking forward to the continued synergy and shared growth ahead.

Table of Contents

Confidentiality Note:

Any information related to the identities of the patient and reporter will be kept confidential unless it is subject to disclose due to regulatory obligation.

AcceptDecline